John Wiley & Sons, Inc.

SHERPA: Unknown

People

  1. Shah
    Shah
  2. Shaha
    Shaha
  3. Patel
    Patel
  4. Lee
    Lee
  5. Ganly
    Ganly
  6. Wong
    Wong
  7. Pfister
    Pfister
  8. Sherman
    Sherman
  9. Cohen
    Cohen
  10. McBride
    McBride

Groups

  1. Surgery (202)
  2. Head and Neck Surgery (183)
  3. Department of Medicine (164)
  4. Survivorship Research (113)
  5. Hematologic Malignancies, Division of (103)
  6. Center for Hematologic Malignancies (96)
  7. Population Sciences Research Program (46)
  8. Solid Tumor Oncology Division (45)
  9. Radiation Oncology, Department of (44)
  10. Center for Pancreatic Cancer Research (39)
Search Within
Formats
  1. Journal Article (390)
  2. Conference Paper (35)
  3. Review (28)
  4. Meeting Abstract (27)
  5. Research Letter (19)
  6. Correspondence (12)
  7. Guidelines (9)
  8. Editorial (3)
Groups
  1. Surgery (202)
  2. Head and Neck Surgery (183)
  3. Department of Medicine (164)
  4. Survivorship Research (113)
  5. Hematologic Malignancies, Division of (103)
  6. Center for Hematologic Malignancies (96)

More Groups

People
  1. Jatin Shah (83)
  2. Ashok Shaha (61)
  3. Snehal Patel (50)
  4. Nancy Lee (40)
  5. Ian Ganly (39)
  6. Dennis Kraus (37)

More People

Years
  1. 2025 (16)
  2. 2024 (19)
  3. 2023 (28)
  4. 2022 (18)
  5. 2021 (29)
  6. 2020 (28)

More Years

Publications
  1. Head & Neck (234)
  2. American Journal of Hematology (130)
  3. Progress in Clinical and Biological Research (60)
  4. Genetic Epidemiology (32)
  5. Journal of Cellular Physiology (25)
  6. Journal of Genetic Counseling (15)

More Publications

Results (523)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis
    Journal Article

    Costa, B. A.; Costa, T. A.; Saravia, S. D.; Felix, N.; Tan, C. R.; Korde, N.; Richter, J.
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Soluble B-cell maturation antigen in multiple myeloma
    Review

    Costa, B. A.; Ortiz, R. J.; Lesokhin, A. M.; Richter, J.
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Evaluation of sort recovery via Rmax
    Journal Article

    Perez-Gonzalez, A.; Lopes, T.; Martinez, L.; Bispo, C.; Gardner, R.; Riddell, A.
    Current Protocols (2024)

    Fulltext@MSK | Save
  • Rebuttal to comment on “concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer”
    Correspondence

    Han, J. E.; Zakeri, K.; Michel, L.; Sherman, E. J.; Lee, N. Y.
    Head & Neck (2024)

    Fulltext@MSK | Save
  • Ecoritamab SSC with rituximab + lenalidomide in patients with relapsed or refractory follicular lymphoma, including patients with POD24: Updated results from EPCORE NHL-2
    Meeting Abstract

    Merryman, R. W.; Belada, D.; Sureda, A.; Leppä, S.; Vermaat, J. S. P.; Holte, H.; Hutchings, M.; Lugtenburg, P.; de Vos, S.; Abrisqueta, P.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Evasion to CD47-targeted phagocytosis in DLBCL
    Meeting Abstract

    Fernandez-Pacheo, F.; Busik, J.; Man, J.; Kolesnick, R.; Wendel, H. G.
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy demonstrates durable efficacy with a manageable safety profile in patients with relapsed/refractory follicular lymphoma who received ≥2 prior therapies: Updated results from a pivotal phase II study
    Meeting Abstract

    Bartlett, N. L.; Sehn, L. H.; Matasar, M. J.; Schuster, S. J.; Assouline, S. E.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Subcutaneous epcoritamab with R-CHOP in previously untreated high-risk diffuse large B-cell lymphoma, including double-hit/triple-hit lymphoma: Updated results from EPCORE NHL-2
    Meeting Abstract

    Falchi, L.; Clausen, M. R.; Offner, F.; de Vos, S.; Brody, J. D.; Kim, M. L.; Snauwaert, S.; Cordoba, R.; Oki, T.; Bykhovski, I.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • A subgroup analysis from MagnetisMM-3: the efficacy and safety of elranatamab by age and frailty in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Raje, N.; Leleu, X.; Lesokhin, A. M.; Mohty , M.; Nooka, A.; Leip, E.; Conte, U.; Vlqueira, A.; Manier, S.
    American Journal of Hematology (2023)

    Fulltext@MSK | Save

    • John Wiley & Sons, Inc. – authorized name for: